PressMarch 10, 2023 Betterlife Publishes Promising Results from a Study Titled “A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders”
PressMarch 9, 2023 Revive Therapeutics Provides Update From Type C Meeting with FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
PressMarch 8, 2023 Numinus Wellness Inc. Executives to Present on Panel at Upcoming South by Southwest Conference
PressMarch 8, 2023 Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial in Major Depressive Disorder Strengthening Topline Efficacy Results
PressMarch 8, 2023 Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference
PressMarch 7, 2023 Safe Supply and Origin Therapeutics Announces Engagement of Research Capital and Upsizing of Brokered Financing To $4 Million
PressMarch 6, 2023 Incannex Engages Catalent for Development and cGMP Manufacture of Psilocybin Drug Product for Clinical Trials and Potential Commercial Use
PressMarch 6, 2023 Mindset Pharma and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin Into Growing Australian Market via Sales Partnership
PressMarch 3, 2023 Incannex Engages Catalent for Development and cGMP Manufacture of Psilocybin Drug Product for Clinical Trials and Potential Commercial Use
PressMarch 3, 2023 GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
PressMarch 3, 2023 COMPASS Pathways to participate in upcoming Cowen 43rd Annual Health Care Conference, Oppenheimer 33rd Annual Healthcare Conference, and Loop Capital Investor Conference
PressMarch 3, 2023 Algernon NeuroScience Appoints Global TBI Expert and Former NFL Neurological Player Care Safety Director Dr. David Brody to Advisory Board
PressMarch 3, 2023 Optimi Health Enters Australian Medical MDMA And Psilocybin Market With Mind Medicine Australia Distribution Agreement
PressFebruary 28, 2023 Field Trip Health & Wellness Provides Business Update and Reports Fiscal Third Quarter 2023 Results
PressFebruary 28, 2023 Original “Shark” and Iconic Entrepreneur Kevin Harrington Joins FSD Pharma Advisory Board
